Osteoporosis International

, Volume 23, Issue 8, pp 2081–2092

The effects of smoking on bone metabolism

Review

Abstract

Osteoporosis is a common, morbid and costly disorder characterized by deterioration in bone strength. Cigarette smoking is associated with reduced bone mineral density (BMD) and increased fracture risk. There are basic, clinical, and observational studies that define several of the underlying pathophysiologic mechanisms that predispose smokers to bone loss. Such mechanisms include alterations in calciotropic hormone metabolism and intestinal calcium absorption, dysregulation in sex hormone production and metabolism, alterations in adrenal cortical hormone metabolism and in the receptor activator of nuclear factor kappa-B (RANK), receptor activator of nuclear factor kappa-B ligand (RANKL), and osteoprotegerin (OPG) system (RANK–RANKL–OPG system), and direct cellular effects of cigarette use on bone cells. In addition, there is evidence of reversibility in the aforementioned mechanisms with smoking cessation. In summary, cigarette smoking is a reversible risk factor for osteoporosis and osteoporotic fractures through diverse pathophysiologic mechanisms.

Keywords

Osteoporosis Smoking Smoking cessation 

References

  1. 1.
    Burge R et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRefGoogle Scholar
  2. 2.
    About osteoporosis. in http://www.nof.org/aboutosteoporosis (2011).
  3. 3.
  4. 4.
    Adachi JD et al (2010) Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin ProcGoogle Scholar
  5. 5.
    Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573–1579PubMedCrossRefGoogle Scholar
  6. 6.
    Kanis JA et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162PubMedCrossRefGoogle Scholar
  7. 7.
    Hopper JL, Seeman E (1994) The bone density of female twins discordant for tobacco use. N Engl J Med 330:387–392PubMedCrossRefGoogle Scholar
  8. 8.
    Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 68:259–270PubMedCrossRefGoogle Scholar
  9. 9.
    Holmberg T et al (2010) Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study—the Danish Health Examination Survey 2007–2008. Osteoporos IntGoogle Scholar
  10. 10.
    (2010) Smoking & tobacco use: trends in current cigarette smoking among high school students and adults, United States, 1965–2010. Center for Disease Control and Prevention, 2010Google Scholar
  11. 11.
    (2011) The tobacco atlas. In http://www.who.int/tobacco/en/atlas38.pdf, Vol. 2011
  12. 12.
    Ma J, Betts NM, Hampl JS (2000) Clustering of lifestyle behaviors: the relationship between cigarette smoking, alcohol consumption, and dietary intake. Am J Health Promot 15:107–117PubMedCrossRefGoogle Scholar
  13. 13.
    Halperin AC, Smith SS, Heiligenstein E, Brown D, Fleming MF (2010) Cigarette smoking and associated health risks among students at five universities. Nicotine Tob Res 12:96–104PubMedCrossRefGoogle Scholar
  14. 14.
    Jones G, Scott FS (1999) A cross-sectional study of smoking and bone mineral density in premenopausal parous women: effect of body mass index, breastfeeding, and sports participation. J Bone Miner Res 14:1628–1633PubMedCrossRefGoogle Scholar
  15. 15.
    Hollenbach KA, Barrett-Connor E, Edelstein SL, Holbrook T (1993) Cigarette smoking and bone mineral density in older men and women. Am J Public Health 83:1265–1270PubMedCrossRefGoogle Scholar
  16. 16.
    Vogel JM, Davis JW, Nomura A, Wasnich RD, Ross PD (1997) The effects of smoking on bone mass and the rates of bone loss among elderly Japanese-American men. J Bone Miner Res 12:1495–1501PubMedCrossRefGoogle Scholar
  17. 17.
    Bjarnason NH, Christiansen C (2000) The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 85:590–596PubMedCrossRefGoogle Scholar
  18. 18.
    Tamaki J et al (2010) Impact of smoking on bone mineral density and bone metabolism in elderly men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos IntGoogle Scholar
  19. 19.
    Pocock NA, Eisman JA, Kelly PJ, Sambrook PN, Yeates MG (1989) Effects of tobacco use on axial and appendicular bone mineral density. Bone 10:329–331PubMedCrossRefGoogle Scholar
  20. 20.
    Flicker L et al (1995) Bone density determinants in elderly women: a twin study. J Bone Miner Res 10:1607–1613PubMedCrossRefGoogle Scholar
  21. 21.
    Ortego-Centeno N et al (1997) Effect of tobacco consumption on bone mineral density in healthy young males. Calcif Tissue Int 60:496–500PubMedCrossRefGoogle Scholar
  22. 22.
    Daniel M, Martin AD, Drinkwater DT (1992) Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcif Tissue Int 50:300–305PubMedCrossRefGoogle Scholar
  23. 23.
    Cox ML, Khan SA, Gau DW, Cox SA, Hodkinson HM (1991) Determinants of forearm bone density in premenopausal women: a study in one general practice. Br J Gen Pract 41:194–196PubMedGoogle Scholar
  24. 24.
    Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA (1994) Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 309:691–695PubMedCrossRefGoogle Scholar
  25. 25.
    Baron JA et al (2001) Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 161:983–988PubMedCrossRefGoogle Scholar
  26. 26.
    Hoidrup S et al (2000) Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol 29:253–259PubMedCrossRefGoogle Scholar
  27. 27.
    Jutberger H et al (2010) Smoking predicts incident fractures in elderly men: Mr OS Sweden. J Bone Miner Res 25:1010–1016PubMedGoogle Scholar
  28. 28.
    Taes Y et al (2010) Early smoking is associated with peak bone mass and prevalent fractures in young, healthy men. J Bone Miner Res 25:379–387PubMedCrossRefGoogle Scholar
  29. 29.
    Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229PubMedCrossRefGoogle Scholar
  30. 30.
    Stolee P, Poss J, Cook RJ, Byrne K, Hirdes JP (2009) Risk factors for hip fracture in older home care clients. J Gerontol A Biol Sci Med Sci 64:403–410PubMedCrossRefGoogle Scholar
  31. 31.
    Jenkins MR, Denison AV (2008) Smoking status as a predictor of hip fracture risk in postmenopausal women of northwest Texas. Prev Chronic Dis 5:A09PubMedGoogle Scholar
  32. 32.
    Robbins J et al (2007) Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 298:2389–2398PubMedCrossRefGoogle Scholar
  33. 33.
    Ojo F, Al Snih S, Ray LA, Raji MA, Markides KS (2007) History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans. J Natl Med Assoc 99:412–418PubMedGoogle Scholar
  34. 34.
    van Geel AC et al (2006) Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study. BMC Med 4:24PubMedCrossRefGoogle Scholar
  35. 35.
    van Staa TP et al (2006) A simple clinical score for estimating the long-term risk of fracture in post-menopausal women. QJM 99:673–682PubMedCrossRefGoogle Scholar
  36. 36.
    Kelsey JL, Prill MM, Keegan TH, Quesenberry CP Jr, Sidney S (2005) Risk factors for pelvis fracture in older persons. Am J Epidemiol 162:879–886PubMedCrossRefGoogle Scholar
  37. 37.
    Bensen R et al (2005) Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord 6:47PubMedCrossRefGoogle Scholar
  38. 38.
    Kato I et al (2000) Diet, smoking and anthropometric indices and postmenopausal bone fractures: a prospective study. Int J Epidemiol 29:85–92PubMedCrossRefGoogle Scholar
  39. 39.
    Forsen L et al (1998) Ex-smokers and risk of hip fracture. Am J Public Health 88:1481–1483PubMedCrossRefGoogle Scholar
  40. 40.
    Forsen L et al (1994) Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture. J Bone Miner Res 9:1671–1678PubMedCrossRefGoogle Scholar
  41. 41.
    Grisso JA et al (1997) Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol 145:786–793PubMedCrossRefGoogle Scholar
  42. 42.
    Grisso JA et al (1994) Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group. N Engl J Med 330:1555–1559PubMedCrossRefGoogle Scholar
  43. 43.
    Cooper C, Barker DJ, Wickham C (1988) Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ 297:1443–1446PubMedCrossRefGoogle Scholar
  44. 44.
    Meyer HE, Tverdal A, Falch JA (1993) Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 137:1203–1211PubMedGoogle Scholar
  45. 45.
    Kiel DP, Baron JA, Anderson JJ, Hannan MT, Felson DT (1992) Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 116:716–721PubMedGoogle Scholar
  46. 46.
    Cummings SR et al (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRefGoogle Scholar
  47. 47.
    Paganini-Hill A, Chao A, Ross RK, Henderson BE (1991) Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 2:16–25PubMedCrossRefGoogle Scholar
  48. 48.
    Paganini-Hill A et al (1981) Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:28–31PubMedGoogle Scholar
  49. 49.
    la Vecchia C, Negri E, Levi F, Baron JA (1991) Cigarette smoking, body mass and other risk factors for fractures of the hip in women. Int J Epidemiol 20:671–677PubMedCrossRefGoogle Scholar
  50. 50.
    Williams AR, Weiss NS, Ure CL, Ballard J, Daling JR (1982) Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 60:695–699PubMedGoogle Scholar
  51. 51.
    Michaelsson K et al (1995) Diet and hip fracture risk: a case–control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment. Int J Epidemiol 24:771–782PubMedCrossRefGoogle Scholar
  52. 52.
    Kreiger N, Gross A, Hunter G (1992) Dietary factors and fracture in postmenopausal women: a case–control study. Int J Epidemiol 21:953–958PubMedCrossRefGoogle Scholar
  53. 53.
    Cumming RG, Klineberg RJ (1994) Case–control study of risk factors for hip fractures in the elderly. Am J Epidemiol 139:493–503PubMedGoogle Scholar
  54. 54.
    FRAX: WHO fracture risk assessment tool. in http://www.shef.ac.uk/FRAX/ (2010).
  55. 55.
    Krall EA, Dawson-Hughes B (1999) Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res 14:215–220PubMedCrossRefGoogle Scholar
  56. 56.
    Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL (2000) Smoking and bone metabolism in elderly women. Bone 27:429–436PubMedCrossRefGoogle Scholar
  57. 57.
    Michnovicz JJ, Hershcopf RJ, Haley NJ, Bradlow HL, Fishman J (1989) Cigarette smoking alters hepatic estrogen metabolism in men: implications for atherosclerosis. Metabolism 38:537–541PubMedCrossRefGoogle Scholar
  58. 58.
    Barbieri RL, Gochberg J, Ryan KJ (1986) Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 77:1727–1733PubMedCrossRefGoogle Scholar
  59. 59.
    Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA (1990) Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 163:1953–1960PubMedGoogle Scholar
  60. 60.
    Rubin RP, Warner W (1975) Nicotine-induced stimulation of steroidogenesis in adrenocortical cells of the cat. Br J Pharmacol 53:357–362PubMedCrossRefGoogle Scholar
  61. 61.
    Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG (1995) The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther 272:151–155PubMedGoogle Scholar
  62. 62.
    Tang TH, Fitzsimmons TR, Bartold PM (2009) Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid. J Clin Periodontol 36:713–718PubMedCrossRefGoogle Scholar
  63. 63.
    Lappin DF, Sherrabeh S, Jenkins WM, Macpherson LM (2007) Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. J Clin Periodontol 34:271–277PubMedCrossRefGoogle Scholar
  64. 64.
    Sorensen LT et al (2010) Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery 148:982–990PubMedCrossRefGoogle Scholar
  65. 65.
    Ma L, Zheng LW, Sham MH, Cheung LK (2010) Uncoupled angiogenesis and osteogenesis in nicotine-compromised bone healing. J Bone Miner Res 25:1305–1313PubMedCrossRefGoogle Scholar
  66. 66.
    Talmage RV, Mobley HT (2008) Calcium homeostasis: reassessment of the actions of parathyroid hormone. Gen Comp Endocrinol 156:1–8PubMedCrossRefGoogle Scholar
  67. 67.
    Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92:4–8PubMedCrossRefGoogle Scholar
  68. 68.
    Norman AW (1979) Vitamin D metabolism and calcium absorption. Am J Med 67:989–998PubMedCrossRefGoogle Scholar
  69. 69.
    Brot C, Jorgensen NR, Sorensen OH (1999) The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 53:920–926PubMedCrossRefGoogle Scholar
  70. 70.
    Szulc P et al (2002) Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 87:666–674PubMedCrossRefGoogle Scholar
  71. 71.
    Need AG et al (2002) Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos Int 13:83–88PubMedCrossRefGoogle Scholar
  72. 72.
    Lorentzon M, Mellstrom D, Haug E, Ohlsson C (2007) Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. J Clin Endocrinol Metab 92:497–503PubMedCrossRefGoogle Scholar
  73. 73.
    Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309PubMedCrossRefGoogle Scholar
  74. 74.
    Paik JM, Farwell WR, Taylor EN (2011) Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos IntGoogle Scholar
  75. 75.
    Kiel DP et al (1996) The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 6:240–248PubMedCrossRefGoogle Scholar
  76. 76.
    Jorde R et al (2005) Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromso study. Eur J Endocrinol 152:39–45PubMedCrossRefGoogle Scholar
  77. 77.
    Krall EA, Dawson-Hughes B (1991) Smoking and bone loss among postmenopausal women. J Bone Miner Res 6:331–338PubMedCrossRefGoogle Scholar
  78. 78.
    Winzenberg TM, Riley M, Frendin S, Oldenburg B, Jones G (2005) Sociodemographic factors associated with calcium intake in premenopausal women: a cross-sectional study. Eur J Clin Nutr 59:463–466PubMedCrossRefGoogle Scholar
  79. 79.
    Prestwood KM et al (1994) The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366–371PubMedCrossRefGoogle Scholar
  80. 80.
    Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRefGoogle Scholar
  81. 81.
    Vega D, Maalouf NM, Sakhaee K (2007) Clinical review: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 92:4514–4521PubMedCrossRefGoogle Scholar
  82. 82.
    Cummings SR et al (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733–738PubMedCrossRefGoogle Scholar
  83. 83.
    Falahati-Nini A et al (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560PubMedCrossRefGoogle Scholar
  84. 84.
    Jick H (1977) Relation between smoking and age of natural menopause. Lancet 309:1354–1355CrossRefGoogle Scholar
  85. 85.
    Mikkelsen TF, Graff-Iversen S, Sundby J, Bjertness E (2007) Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: a cross-sectional study. BMC Public Health 7:149PubMedCrossRefGoogle Scholar
  86. 86.
    Jensen J, Christiansen C, Rodbro P (1985) Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 313:973–975PubMedCrossRefGoogle Scholar
  87. 87.
    Whitcomb BW et al (2010) Ovarian function and cigarette smoking. Paediatr Perinat Epidemiol 24:433–440PubMedCrossRefGoogle Scholar
  88. 88.
    Brand JS et al (2011) Cigarette smoking and endogenous sex hormones in postmenopausal women. J Clin Endocrinol MetabGoogle Scholar
  89. 89.
    Mellstrom D et al (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529–535PubMedCrossRefGoogle Scholar
  90. 90.
    Stuermer EK et al (2009) Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats. World J Urol 27:547–555PubMedCrossRefGoogle Scholar
  91. 91.
    Amory JK et al (2004) Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503–510PubMedCrossRefGoogle Scholar
  92. 92.
    Colvard DS et al (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A 86:854–857PubMedCrossRefGoogle Scholar
  93. 93.
    Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302PubMedCrossRefGoogle Scholar
  94. 94.
    Amin S et al (2006) Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119:426–433PubMedCrossRefGoogle Scholar
  95. 95.
    Meier C et al (2008) Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 168:47–54PubMedCrossRefGoogle Scholar
  96. 96.
    Benito M et al (2003) Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab 88:1497–1502PubMedCrossRefGoogle Scholar
  97. 97.
    Cawthon PM et al (2009) Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 94:3806–3815PubMedCrossRefGoogle Scholar
  98. 98.
    Halmenschlager G, Rossetto S, Lara GM, Rhoden EL (2009) Evaluation of the effects of cigarette smoking on testosterone levels in adult men. J Sex Med 6:1763–1772PubMedCrossRefGoogle Scholar
  99. 99.
    Saadat M (2009) Serum levels of testosterone and gonadotrophins with respect to smoking status and genetic polymorphism of GSTT1. Mol Biol Rep 36:1353–1356PubMedCrossRefGoogle Scholar
  100. 100.
    Shiels MS et al (2009) Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control 20:877–886PubMedCrossRefGoogle Scholar
  101. 101.
    Trummer H, Habermann H, Haas J, Pummer K (2002) The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 17:1554–1559PubMedCrossRefGoogle Scholar
  102. 102.
    Direk N, Newson RS, Hofman A, Kirschbaum C, Tiemeier H (2011) Short and long-term effects of smoking on cortisol in older adults. Int J Psychophysiol 80:157–160PubMedCrossRefGoogle Scholar
  103. 103.
    Khaw KT, Tazuke S, Barrett-Connor E (1988) Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318:1705–1709PubMedCrossRefGoogle Scholar
  104. 104.
    Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282PubMedCrossRefGoogle Scholar
  105. 105.
    Jia D, O’Brien CA, Stewart SA, Manolagas SC, Weinstein RS (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147:5592–5599PubMedCrossRefGoogle Scholar
  106. 106.
    Morris HA et al (1990) Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcif Tissue Int 46:305–308PubMedCrossRefGoogle Scholar
  107. 107.
    Reid IR, Ibbertson HK (1987) Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 27:200–204PubMedCrossRefGoogle Scholar
  108. 108.
    Kristo C et al (2002) Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing’s syndrome. Eur J Endocrinol 146:389–395PubMedCrossRefGoogle Scholar
  109. 109.
    Oakley AE et al (2009) Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: influence of ovarian steroids. Endocrinology 150:341–349PubMedCrossRefGoogle Scholar
  110. 110.
    Oncken C et al (2002) Effects of smoking cessation or reduction on hormone profiles and bone turnover in postmenopausal women. Nicotine Tob Res 4:451–458PubMedCrossRefGoogle Scholar
  111. 111.
    Yeh J, Barbieri RL (1989) Twenty-four-hour urinary-free cortisol in premenopausal cigarette smokers and nonsmokers. Fertil Steril 52:1067–1069PubMedGoogle Scholar
  112. 112.
    Fang MA, Frost PJ, Iida-Klein A, Hahn TJ (1991) Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells. Bone 12:283–286PubMedCrossRefGoogle Scholar
  113. 113.
    Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R (2009) Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab 27:555–561PubMedCrossRefGoogle Scholar
  114. 114.
    Walker LM, Preston MR, Magnay JL, Thomas PB, El Haj AJ (2001) Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone 28:603–608PubMedCrossRefGoogle Scholar
  115. 115.
    Villablanca AC (1998) Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84:2089–2098PubMedGoogle Scholar
  116. 116.
    Hapidin H et al (2007) Negative effects of nicotine on bone-resorbing cytokines and bone histomorphometric parameters in male rats. J Bone Miner Metab 25:93–98PubMedCrossRefGoogle Scholar
  117. 117.
    Kamer AR, El-Ghorab N, Marzec N, Margarone JE 3rd, Dziak R (2006) Nicotine induced proliferation and cytokine release in osteoblastic cells. Int J Mol Med 17:121–127PubMedGoogle Scholar
  118. 118.
    Yuhara S et al (1999) Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone. Eur J Pharmacol 383:387–393PubMedCrossRefGoogle Scholar
  119. 119.
    Tanaka H et al (2006) Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci 78:1733–1740PubMedCrossRefGoogle Scholar
  120. 120.
    Liu X et al (2003) Cigarette smoke extract inhibits chemotaxis and collagen gel contraction mediated by human bone marrow osteoprogenitor cells and osteoblast-like cells. Osteoporos Int 14:235–242PubMedGoogle Scholar
  121. 121.
    Liu XD et al (2001) Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture. J Lab Clin Med 137:208–219PubMedCrossRefGoogle Scholar
  122. 122.
    Ajiro Y, Tokuhashi Y, Matsuzaki H, Nakajima S, Ogawa T (2010) Impact of passive smoking on the bones of rats. Orthopedics 33:90–95PubMedCrossRefGoogle Scholar
  123. 123.
    Simonet WS et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319PubMedCrossRefGoogle Scholar
  124. 124.
    Burgess TL et al (1999) The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527–538PubMedCrossRefGoogle Scholar
  125. 125.
    Bolon B et al (2001) Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. Mol Ther 3:197–205PubMedCrossRefGoogle Scholar
  126. 126.
    Lacey DL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176PubMedCrossRefGoogle Scholar
  127. 127.
    Giorgetti AP et al (2010) Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:447–452PubMedCrossRefGoogle Scholar
  128. 128.
    Nelson HD, Nevitt MC, Scott JC, Stone KL, Cummings SR (1994) Smoking, alcohol, and neuromuscular and physical function of older women. Study of Osteoporotic Fractures Research Group. JAMA 272:1825–1831PubMedCrossRefGoogle Scholar
  129. 129.
    Gerdhem P, Obrant KJ (2002) Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporos Int 13:932–936PubMedCrossRefGoogle Scholar
  130. 130.
    Cornuz J, Feskanich D, Willett WC, Colditz GA (1999) Smoking, smoking cessation, and risk of hip fracture in women. Am J Med 106:311–314PubMedCrossRefGoogle Scholar
  131. 131.
    Oncken C et al (2006) Impact of smoking cessation on bone mineral density in postmenopausal women. J Womens Health (Larchmt) 15:1141–1150CrossRefGoogle Scholar
  132. 132.
    Dome P (2011) Over-the-counter nicotine replacement therapy for everyone: is it the best solution? Med HypothesesGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2012

Authors and Affiliations

  1. 1.The Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Department of Internal MedicineUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations